Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

BIOLASE (BIOLQ) Stock Price & Analysis

1,631 Followers

BIOLQ Stock Chart & Stats

$0.00$0.00(0.00%)
At close: 9:31 AM EDT
$0.01$0.012$0.014Apr 14Apr 28May 12May 27Jun 9Jun 23Jul 10
Day’s Range
$0.01 - $0.01
52-Week Range
$0.01 - $0.01
Previous Close
$0.01
Volume
N/A
Average Volume (3M)
72.20K
Market Cap
$3,660
Enterprise Value
$16.44M
Total Cash (Recent Filing)
N/A
Total Debt (Recent Filing)
$18.16M
Price to Earnings (P/E)
―
Beta
105.16
Next Earnings
N/A
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Product Innovation

BIOLASE's focus on innovative dental laser systems positions it well in the medical device sector, offering minimally invasive solutions that can drive long-term adoption and market share growth.

Market Position

By specializing in dental applications within the medical device sector, BIOLASE can leverage its expertise to maintain a competitive edge and potentially expand its market presence.

Revenue Diversification

BIOLASE's diversified revenue streams, including product sales, training, and partnerships, provide a stable foundation for long-term growth and resilience against market fluctuations.

Bears Say

Financial Challenges

Ongoing financial challenges, including persistent losses and high leverage, threaten BIOLASE's financial stability and ability to invest in growth opportunities.

Cash Flow Issues

Chronic negative free cash flow indicates inefficiencies in cash management, which could hinder BIOLASE's ability to sustain operations and invest in future growth.

Revenue Decline

The decline in revenue growth reflects challenges in market expansion and customer acquisition, potentially impacting BIOLASE's long-term competitiveness and profitability.

BIOLASE News

BIOLQ FAQ

What was BIOLASE’s price range in the past 12 months?
BIOLASE lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is BIOLASE’s market cap?
BIOLASE’s market cap is $3,660.
When is BIOLASE’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were BIOLASE’s earnings last quarter?
BIOLASE released its earnings results on Nov 06, 2024. The company reported -$0.038 earnings per share for the quarter, beating the consensus estimate of -$0.08 by $0.042.
Is BIOLASE overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does BIOLASE pay dividends?
BIOLASE does not currently pay dividends.
What is BIOLASE’s EPS estimate?
BIOLASE’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BIOLASE have?
BIOLASE has 36,597,000 shares outstanding.
What happened to BIOLASE’s price movement after its last earnings report?
BIOLASE reported an EPS of -$0.038 in its last earnings report, beating expectations of -$0.08. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of BIOLASE?
Hedge funds hold BIOLASE shares: the largest hedge-fund position in BIOLASE is 67,933,906 shares, and hedge funds decreased their holdings by 185.1K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology